|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Shi J, Zhu L, Liu S and Xie WF: A
meta-analysis of case-control studies on the combined effect of
hepatitis B and C virus infections in causing hepatocellular
carcinoma in China. Brit J Cancer. 92:607–612. 2005.
|
|
3
|
Chang MH, You SL, Chen CJ, et al; Taiwan
Hepatoma Study Group. Decreased incidence of hepatocellular
carcinoma in hepatitis B vaccinees: a 20-year follow-up study. J
Natl Cancer Inst. 101:1348–1355. 2009.
|
|
4
|
Papatheodoridis GV, Lampertico P,
Manolakopoulos S and Lok A: Incidence of hepatocellular carcinoma
in chronic hepatitis B patients receiving nucleos(t)ide therapy: a
systematic review. J Hepatol. 53:348–356. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Shiratori Y, Ito Y, Yokosuka O, et al;
Tokyo-Chiba Hepatitis Research Group. Antiviral therapy for cirρtic
hepatitis C: association with reduced hepatocellular carcinoma
development and improved survival. Ann Intern Med. 142:105–114.
2005.
|
|
6
|
Hatanaka K, Kudo M, Fukunaga T, et al:
Clinical characteristics of NonBNonC- HCC: Comparison with HBV and
HCV related HCC. Intervirology. 50:24–31. 2007. View Article : Google Scholar
|
|
7
|
Llovet JM and Bruix J: Novel advancements
in the management of hepatocellular carcinoma in 2008. J Hepatol.
48(Suppl 1): S20–S37. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Lencioni R, Chen XP, Dagher L and Venook
AP: Treatment of intermediate/advanced hepatocellular carcinoma in
the clinic: how can outcomes be improved? Oncologist. 15(Suppl 4):
S42–S52. 2010. View Article : Google Scholar
|
|
9
|
Llovet JM and Bruix J: Systematic review
of randomized trials for unresectable hepatocellular carcinoma:
Chemoembolization improves survival. Hepatology. 37:429–442. 2003.
View Article : Google Scholar
|
|
10
|
Nagaoki Y, Hyogo H, Aikata H, et al:
Recent trend of clinical features in patients with hepatocellular
carcinoma. Hepatol Res. 42:368–375. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Koh WP, Wang R, Jin A, Yu MC and Yuan JM:
Diabetes mellitus and risk of hepatocellular carcinoma: findings
from the Singapore Chinese Health Study. Brit J Cancer.
108:1182–1188. 2013. View Article : Google Scholar
|
|
12
|
Djiogue S, Nwabo Kamdje AH, Vecchio L, et
al: Insulin resistance and cancer: the role of insulin and IGFs.
Endocr Relat Cancer. 20:R1–R17. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Mehta NN, McGillicuddy FC, Anderson PD, et
al: Experimental endotoxemia induces adipose inflammation and
insulin resistance in humans. Diabetes. 59:172–181. 2010.
View Article : Google Scholar
|
|
14
|
Grivennikov SI, Greten FR and Karin M:
Immunity, inflammation, and cancer. Cell. 140:883–899. 2010.
View Article : Google Scholar
|
|
15
|
Alison MR, Nicholson LJ and Lin WR:
Chronic inflammation and hepatocellular carcinoma. Recent Results
Cancer Res. 185:135–148. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Ting CT, Chen RC, Chen CC, Liu MH, Chu D
and Kuo NW: Diabetes worsens the surgical outcomes in cirρtic
patients with hepatocellular carcinoma. Tohoku J Exp Med.
227:73–81. 2012.PubMed/NCBI
|
|
17
|
Huo TI, Hsu CY, Huang YH, et al: Diabetes
mellitus as an independent prognostic predictor and its association
with renal dysfunction in patients with hepatocellular carcinoma.
Liver Int. 30:198–207. 2010. View Article : Google Scholar
|
|
18
|
Huo TI, Wu JC, Lui WY, et al: Differential
mechanism and prognostic impact of diabetes mellitus on patients
with hepatocellular carcinoma undergoing surgical and nonsurgical
treatment. Am J Gastroenterol. 99:1479–1487. 2004. View Article : Google Scholar
|
|
19
|
Limaye AR, Clark V, Soldevila-Pico C, et
al: Neutrophil-lymphocyte ratio predicts overall and
recurrence-free survival after liver transplantation for
hepatocellular carcinoma. Hepatol Res. 43:757–764. 2012. View Article : Google Scholar
|
|
20
|
Bruix J and Sherman M; Practice Guidelines
Committee, American Association for the Study of Liver Diseases.
Management of hepatocellular carcinoma. Hepatology. 42:1208–1236.
2005. View Article : Google Scholar
|
|
21
|
Lagiou P, Kuper H, Stuver SO, Tzonou A,
Trichopoulos D and Adami HO: Role of diabetes mellitus in the
etiology of hepatocellular carcinoma. J Natl Cancer Inst.
92:1096–1099. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Shau WY, Shao YY, Yeh YC, et al: Diabetes
mellitus is associated with increased mortality in patients
receiving curative therapy for hepatocellular carcinoma.
Oncologist. 17:856–862. 2012. View Article : Google Scholar
|
|
23
|
Kaibori M, Ishizaki M, Matsui K, Kitade H,
Matsui Y and Kwon AH: Evaluation of metabolic factors on the
prognosis of patients undergoing resection of hepatocellular
carcinoma. J Gastroenterol Hepatol. 26:536–543. 2011. View Article : Google Scholar
|
|
24
|
Kawamura Y, Ikeda K, Arase Y, et al:
Diabetes mellitus worsens the recurrence rate after potentially
curative therapy in patients with hepatocellular carcinoma
associated with nonviral hepatitis. J Gastroenterol Hepatol.
23:1739–1746. 2008. View Article : Google Scholar
|
|
25
|
Connolly GC, Safadjou S, Kashyap R, Chen
R, Orloff MS and Hezel AF: Diabetes mellitus impacts risk of
macrovascular invasion in patients undergoing transplantation for
hepatocellular carcinoma. BMC Gastroenterol. 13:92013. View Article : Google Scholar
|
|
26
|
Giannelli G, Pierri F, Trerotoli P, et al:
Occurrence of portal vein tumor thrombus in hepatocellular
carcinoma affects prognosis and survival: A retrospective clinical
study of 150 cases. Hepatol Res. 24:502002. View Article : Google Scholar
|
|
27
|
Zhao WC, Fan LF, Yang N, Zhang HB, Chen BD
and Yang GS: Preoperative predictors of microvascular invasion in
multinodular hepatocellular carcinoma. Eur J Surg Oncol.
39:858–864. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
McNally ME, Martinez A, Khabiri H, et al:
Inflammatory markers are associated with outcome in patients with
unresectable hepatocellular carcinoma undergoing transarterial
chemoembolization. Ann Surg Oncol. 20:923–928. 2013. View Article : Google Scholar
|
|
29
|
Tavares-Murta BM, Mendonça MA, Duarte NL,
et al: Systemic leukocyte alterations are associated with invasive
uterine cervical cancer. Int J Gynecol Cancer. 20:1154–1159. 2010.
View Article : Google Scholar
|
|
30
|
Imai Y, Kubota Y, Yamamoto S, et al:
Neutrophils enhance invasion activity of human cholangiocellular
carcinoma and hepatocellular carcinoma cells: an in vitro study. J
Gastroenterol Hepatol. 20:287–293. 2005. View Article : Google Scholar
|
|
31
|
McDonald B, Spicer J, Giannais B,
Fallavollita L, Brodt P and Ferri LE: Systemic inflammation
increases cancer cell adhesion to hepatic sinusoids by neutrophil
mediated mechanisms. Int J Cancer. 125:1298–1305. 2009. View Article : Google Scholar
|
|
32
|
Wu Y, Zhao Q, Peng C, Sun L, Li XF and
Kuang DM: Neutrophils promote motility of cancer cells via a
hyaluronan-mediated TLR4/PI3K activation loop. J Pathol.
225:438–447. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Siddique A and Kowdley KV: Insulin
resistance and other metabolic risk factors in the pathogenesis of
hepatocellular carcinoma. Clin Liver Dis. 15:281–296. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Oh JS, Kucab JE, Bushel PR, et al:
Insulin-like growth factor-1 inscribes a gene expression profile
for angiogenic factors and cancer progression in breast epithelial
cells. Neoplasia. 4:204–217. 2002. View Article : Google Scholar
|
|
35
|
Piecewicz SM, Pandey A, Roy B, Xiang SH,
Zetter BR and Sengupta S: Insulin-like growth factors promote
vasculogenesis in embryonic stem cells. PloS One. 7:e321912012.
View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Brandau S, Dumitru CA and Lang S: Protumor
and antitumor functions of neutrophil granulocytes. Semin
Immunopathol. 35:163–176. 2013. View Article : Google Scholar
|
|
37
|
Zhang JB, Chen Y, Zhang B, et al:
Prognostic significance of serum gamma-glutamyl transferase in
patients with intermediate hepatocellular carcinoma treated with
transcatheter arterial chemoembolization. Eur J Gastroenterol
Hepatol. 23:787–793. 2011. View Article : Google Scholar
|
|
38
|
Oh BS, Jang JW, Kwon JH, et al: Prognostic
value of C-reactive protein and neutrophil-to-lymphocyte ratio in
patients with hepatocellular carcinoma. BMC cancer. 13:782013.
View Article : Google Scholar : PubMed/NCBI
|
